Loading…
Lobbying Spend
—
Filings
7
Firms Hired
1
Active Period
2007–2008
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Biologics Price Competition and Innovation Act of 2007
2008 · third_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
FDA drug approval process S.1695-Biologics Price Competition and Innovation Act
Client expense: — · Firm income: $90,000
Matched citations: S.1695
Biologics Price Competition and Innovation Act of 2007
2008 · third_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
FDA drug approval process S.1695-Biologics Price Competition and Innovation Act
Client expense: — · Firm income: $90,000
Matched citations: S.1695
Biologics Price Competition and Innovation Act of 2007
2008 · second_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
FDA drug approval process S.1695-Biologics Price Competition and Innovation Act
Client expense: — · Firm income: $90,000
Matched citations: S.1695
Biologics Price Competition and Innovation Act of 2007
2008 · second_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
FDA drug approval process S.1695-Biologics Price Competition and Innovation Act
Client expense: — · Firm income: $90,000
Matched citations: S.1695
Biologics Price Competition and Innovation Act of 2007
2008 · first_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
FDA drug approval process S.1695-Biologics Price Competition and Innovation Act
Client expense: — · Firm income: $90,000
Matched citations: S.1695
Biologics Price Competition and Innovation Act of 2007
2008 · first_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
FDA drug approval process S.1695-Biologics Price Competition and Innovation Act
Client expense: — · Firm income: $90,000
Matched citations: S.1695
Biologics Price Competition and Innovation Act of 2007
2007 · year_end · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
FDA drug approval process S.1695-Biologics Price Competition and Innovation Act
Client expense: — · Firm income: $260,000
Matched citations: S.1695
Biologics Price Competition and Innovation Act of 2007
2007 · year_end · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
FDA drug approval process S.1695-Biologics Price Competition and Innovation Act
Client expense: — · Firm income: $260,000
Matched citations: S.1695
Biologics Price Competition and Innovation Act of 2007
2007 · mid_year · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
FDA drug approval process S.1695-Biologics Price Competition and Innovation Act
Client expense: — · Firm income: —
Matched citations: S.1695
Biologics Price Competition and Innovation Act of 2007
2007 · mid_year · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
FDA drug approval process S.1695-Biologics Price Competition and Innovation Act
Client expense: — · Firm income: —
Matched citations: S.1695
Source: Senate LDA